key: cord-0959815-386fthqf
authors: Butcher, Robyn; Sampson, Margaret; Couban, Rachel J.; Malin, James Edward; Loree, Sara; Brody, Stacy
title: The currency and completeness of specialized databases of COVID-19 publications
date: 2022-03-24
journal: J Clin Epidemiol
DOI: 10.1016/j.jclinepi.2022.03.006
sha: 851481cd0e1c52a04e9a0b2f2c9f208aa8cf3469
doc_id: 959815
cord_uid: 386fthqf

Objective Several specialized collections of COVID-19 literature have been developed during the global health emergency. These include the WHO COVID-19 Global Literature Database, Cochrane COVID-19 Study Register, CAMRADES COVID-19 SOLES, Epistemonikos’ COVID-19 L-OVE and LitCovid. Our objective was to evaluate the completeness of these collections and to measure the time from when COVID-19 articles are posted to when they appear in the collections. Study Design and Setting We tested each selected collection for the presence of 440 included studies from 25 COVID-19 systematic reviews. We sampled 112 journals and prospectively monitored their websites until a new COVID-19 article appeared. We then monitored for two weeks to see when the new articles appeared in each collection. PubMed served as a comparator. Results Every collection provided at least one record not found in PubMed. Four records (1%) were not in any of the sources studied. Collections contained between 83% and 93% of the primary studies with the WHO database being most complete. By two weeks, between 60% and 78% of tracked articles had appeared. Conclusions Our findings support the use of the best performing Covid-19 collections by systematic reviews to replace paywalled databases.

COVID-19 became the dominant subject of the scientific and medical literature in 2020. Finding the latest research has become a time-consuming task for decision-makers and stakeholders as the volume of literature continues to grow. To address this problem, several groups have developed specialized collections of COVID-19 literature. These include the WHO COVID-19 Global literature on coronavirus disease, The Cochrane Collaboration's COVID-19 Study Register, CAMARADES COVID-19-SOLES, Epistemonikos' COVID-19 L-OVE and the United States National Library of Medicine's LitCovid.

Every collection is curated, and the inclusion criteria differ between the databases. However, the purpose of all collections is to create centralized repositories of COVID-19 literature for simplified access and discovery.

Each collection has a different methodology for identifying material to include. All involve regular human and/or machine searching and screening of bibliographic databases such as PubMed, Embase, as well as preprint sites, journal publishers' websites and, in some cases, other collections such as the CDC and WHO COVID-19 websites. Except for LitCovid, all include preprints All the collections describe their methodology on their websites.

Those undertaking evidence synthesis projects can search any of these specialized collections along with standard methods such as searching bibliographic databases, study registries, checking reference lists, and contacting researchers. Or, if their currency and completeness could be demonstrated, a COVID-19 collection could be a single source for rapid evidence synthesis. Our research question asks, "how current and how complete are the COVID-19 collections?"

1.1 Objectives 1) To evaluate the completeness of the collections.

2) To measure the time from when COVID-19 articles are posted by journals at the journal website to when they are retrievable from the specialized collections..

This study is divided into two parts: currency and completeness.

The following collections were selected for study: WHO COVID-19 Global Literature Database (WHO), COMRADES COVID-19 SOLES (SOLES), Cochrane COVID-19 study register (Cochrane), United States National Library of Medicine's LitCovid (LitCovid) and Epistemonikos' COVID-19 L-OVE (Epistemonikos). The criteria for selection were that the collections had to be established and functional as of April 2020, when we started the study. COVID-19 must be the primary focus of the databases. Resources had to have at least a basic search function. Living Systematic Reviews or datasets that only allowed browsing were excluded. PubMed was also searched as a comparator

Methods are based on proven methods for studying database completeness 1-5 and the methodology used in a recent Cochrane COVID-19 Study Register Sensitivity Evaluation, 6 We used the included studies from systematic reviews that met the eligibility criteria described J o u r n a l P r e -p r o o f below until we had gathered a sample of 500 references. These references were then searched in each of the COVID-19 specialized collections under study to determine how many were contained in each collection. The systematic reviews were selected from the Epistemonikos' COVID-19 L-OVE. Any study classified as a systematic review by Epistemonikos was eligible if it otherwise met the criteria, regardless of the terminology used by the authors (such as meta-analyses, qualitative reviews, or rapid reviews, for example), and regardless of the language of publication.

We sought a mix of interventional, diagnostic, prediction, and observational reviews as described in the selection process below. To be eligible, systematic reviews must have reported searching at least four databases. A minimum of five included studies from each review must have been published or posted in 2020. For reviews with fewer than five included studies, all must have been published or posted in 2020. Note that we completed this portion of the study in 2020.

The selection process for systematic reviews Systematic reviews were considered in sequence as they were listed in each of the five Epistemonikos categories (Prevention/Treatment, Diagnosis, Etiology, Epidemiology, and Prognosis). Once an eligible review was identified, the count of its eligible included primary studies was made. A review was then selected from the next category. This continued until 500 primary studies were identified.

Five reviewers (RB, MS, RC, JM, SL) screened reviews and extracted primary studies. If ineligible, the main exclusion reason was noted. In all cases, the sources that were searched, and the number of studies included in the review were recorded. Once 100 primary studies were identified from each category, the sets were examined for duplicate primary studies.

Based on the Epistemonikos' COVID-19 L-OVE, we estimated that there were 8778 primary studies relevant to COVID-19 as of July 24, 2020. A five percent sample would have been 440 studies. We screened systematic reviews until we identified 500 primary studies with the expectation that there would be duplicate studies among the systematic reviews.

Studies must have been cited as an included study in one of the systematic reviews selected. Studies must have been primary studies but could be in published articles, preprints, conference abstracts or trial registrations.. No restrictions were imposed based on the language of publication.

Publications without primary data were excluded. This included protocols or trial registrations that did not report results. Smart phone applications or datasets that were included in systematic reviews were excluded. If a systematic review included more than 50 primary studies, the first 50, as they appeared in the reference list, were selected

Primary studies were assigned to searchers who searched for each of the studies in each specialized COVID-19 collection and recorded its presence or absence. Searchers were drawn from the registered searchers of the Librarian Reserve Corps 7 and are named in section 6.0.

Searchers could search using the DOI, by a search string composed of author and title fragments or any other combination of features the searchers determined was suitable for the study and collection being searched. The searchers could make more than one attempt to retrieve the items, until satisfied that they were present or not in the collection. If a study was found to be present in that collection, the date added to the collection was recorded, when available. This work occurred in December, 2020. See protocol section "Determination of inclusion in COVID-19 collection" for more detail.

The primary outcome measure was completeness, defined as the proportion of relevant primary studies found in a collection. The denominator was adjusted for the Cochrane collection as its inclusion criteria were narrower than those of the other collections. Each record not found in the Cochrane collection was assessed by one investigator (RB) and reviewed by a second investigator (MS) to determine if it was in scope for that collection.

The inclusion status of each selected study was shared with the database creators to allow them to audit any missed studies as a quality control measure.

We sought a sample of 50 newly appearing studies to track in the databases. One hundred and twelve journals were selected and tracked daily. Once a newly released article (preprint or final) relevant to the COVID-19 pandemic was identified on a journal website, tracking of that journal was halted. The identified article was then searched for in each of the collections each weekday until it appeared or until a two-week observation period had ended. This process continued until we accrued 50 studies.

Journals were selected from a list created by searching Web of Science with default settings and the search string "COVID-19". Web of Science, all segments, was chosen to ensure that all aspects of the COVID-19 pandemic, including economic and social aspects, were included. This search yielded 64,032 records on January 5, 2021. The Web of Science "analyze" feature was used to obtain a list of journals sorted by the number of publications. We retained journals that, when sorted by the number of publications, accounted for two-thirds of the total number of publications. This equated to a cut point of 16 or more articles. Note that we included all journals with 16 or more articles although this put us slightly over the two-thirds mark (66.98%). To select 50 journals from this set, we selected every 11 th journal, sorted by the number of articles retrieved from that journal. We added a margin of 10 journals (20%) in anticipation that some of these journals would not publish another COVID-19 article within 30 days. . When this did not yield enough studies, we drew a second sample of 50 journals, starting at the seventh journal in the original list and selecting every 11 th from that point (Appendix 1)

The selected journals were divided into sets of 6 journals and distributed to 10 searchers. Five searchers similarly tracked the second sample following the end of the first observation period. This work occurred from January to April, 2021.

To be eligible, the article must deal with COVID-19 or a topic relevant to the COVID-19 pandemic response, such as personal protective equipment, and present the results of a primary study. The article must be either a preprint in peer review or an article accepted by the journal, whether in manuscript or published form and have a DOI. Protocols, editorials, commentaries, discussion papers, and guidance articles that do not present primary results were excluded. There were no restrictions based on the language of publication.

Once a relevant article was identified, the searcher stopped checking the journal site and began tracking that article daily (weekdays only) until its date of appearance in each of the collections or until the end of the observation period, two weeks from appearance. Beyond two weeks, the collection was deemed to be "not current" for that article; otherwise, the date of appearance was recorded.

Upon completion of tracking, articles were classified by two investigators (JM, MS), reaching consensus, on the dimensions of the population studied (human/animal/other) and for clinical studies, the study design and question type: therapy (prevention/treatment), diagnosis, etiology, epidemiology, prognosis or other.

One hundred and one systematic reviews were examined to identify 25 eligible systematic reviews. Characteristics of the systematic review that were screened and selected are presented in Table 1 . Sources searched in the reviews are shown in Table 2 . PubMed was the most frequently searched source, used in 62 of the 101 systematic reviews examined. Of the specialized collections, WHO or CDC were searched in 13 and Epistemonikos was searched in 3. Lit-Covid, Cochrane and SOLES were not searched by any of the systematic reviews examined. Following duplicate removal, 440 primary studies were searched to determine their inclusion status in each of the COVID-19 collections. Study flow is illustrated in Figure 1 . Four publications were not found in any of the collections. We examined all possible pairs of databases and looked at the overlap and unique publications. In any pairing, both databases contributed records not found in the other. This ranged from five records found in COVID-19 SOLES that were not found in WHO to 60 records found in Epistemonikos' COVID-19 L-OVE that were not found in COVID-19 SOLES. Of greater practical interest is the gain from each database beyond what was available from PubMed (Table 4 ). Illustated are the absolute and relative yield of publications of interest that were not included in PubMed. The diagonal represents the number of records found in that database and not found in PubMed. Other cells in the table show the unique records in the column database relative the database shown in the row. As an example, Table 4 shows that Epistimonikos has 46 records not found in PubMed. Seven of these were not found in the WHO database and 29 were not found in LitCovid. Looking at the next column, the WHO had 40 records not found in PubMed. Of these, 4 were not found in Epistimonikos, 29 were not found in LitCovid, and so on.

Six publications of interest were found in only one of the collections studied. Epistemonikos had four of these unique publications, Cochrane and PubMed had one unique publication each.

One hundred and twelve journals were monitored to yield eligible studies published by fifty journals within the monitoring period. Characteristics of primary studies Forty-four of the 50 studies (88%) were human studies, one (2%) involved both humans and animals and five (10%) were laboratory, simulation, or health systems studies.

Forty-one (82%) of the articles pertained to clinical studies. We classified those according to the type of question asked and the study design used. The largest group of clinical studies involved epidemiological questions (17 studies, 41.5% of clinical studies), followed by prevention or treatment (10, 24.4%) and etiology or harms (8, 19 .5%) ( Table 5 ). See supplemental material for the study designs found in the sample of studies. (Table A4) . We considered a collection to be current for an article if that article appeared in the collection within two weeks of appearing on the journal website. Our a priori primary outcome is the proportion of in-scope tracked articles identifiable in a collection within three days of appearance at the journal site. The proportion available at 1, 5, 7, 10 and 14 days is also reported, by collection (Table 6 ). For our primary outcome, PubMed had 27/50 articles (74%) at day three, substantially more than any other collection examined. The WHO collection included 72% of our test articles within 2 weeks, but accrued these articles more slowly than PubMed. The median time to the appearance of these articles was five days for the WHO collection. SOLES showed the slowest accrual, with a median of eight days to appearance and it contained only 60% of the target articles by the two-week mark ( Table 6 ). *Denominator corrected. Epistemonikos identified 2 of the target articles as "excluded". Nine of the target articles were assessed as out of scope for the Cochrane collection by one investigator (RB) and verified by a second investigator (MS). †Calculated using articles that appeared within the 2-week monitoring period. ‡ Proportion of in-scope tracked articles identifiable in a collection within three days of appearance at the journal site was our primary outcome for the currency portion.

Considering completeness, none of the specialized collections studied here included all publications of interest. Three of the six collections had unique records, but only six records were unique to one source, and only one source had more than one unique record. The contribution of each database beyond material found in PubMed is important. PubMed indexed 87.5% of publications of interest. It is the benchmark against which other collections must be measured when considering completeness. It has the best-developed search features and thus PubMed records may be much easier to retrieve through subject searching than those found in the specialized collections. We tested for the presence of records using knownitem searching by skilled searchers drawn from the Librarian Reserve Corps. Presence in the collection does not assure that a record would be retrieved. Factors of interface features and searcher skill will limit retrieval success.

Tests of retrieval through subject searching would be necessary to fully assess the functionality of these collections, and this is beyond the scope of this study. However, our searchers reported usability issues with some of the collections, so we tabulated their basic features (Appendix 3).

Searching involves a trade-off between recall of relevant items and the number needed to read (NNR) to identify one relevant record. A search of PubMed may retrieve many records not relevant to the question at hand because of its breadth of coverage. Special collections have the benefit of very high precision and a low NNR. The ideal combination of sources depends on factors such as subject coverage, access to the source and the skill of the searcher.

All specialized collections studied here contained more than 80% of the publications of interest. Yet, except for PubMed, they were rarely, if ever, used as sources in early COVID-19 systematic reviews (Table 2 ). This may have been due to a lack of awareness or confidence in their completeness. Our findings support their use and they could replace paywalled databases often used to conduct systematic reviews. All sources studied here are open access while four of the five databases searched most often in our sample of systematic reviews, shown in Table 2 , are available only through subscription.

Special COVID-19 collections were not able to identify and include articles faster than PubMed. The next most complete collection at the three-day point was LitCovid, a derivative of PubMed produced by the National Library of Medicine, followed by Epistemonikos, WHO, Cochrane, and finally SOLES. Measured at 2 weeks, WHO was current for the most articles, followed by PubMed, LitCovid, Epistemonikos, Cochrane, and SOLES, in that order.

Comparing this to the results from the completeness portion of this study, where the order (from most complete to least complete) was Epistemonikos, WHO, LitCovid, PubMed, SOLES and Cochrane, we see some differences in the order, but with strong performances by the first four databases in both currency and completeness.

There have been other studies that evaluated completeness and currency of special COVID-19 collections that looked at one or two of the collections but not all five. Pierre et al. examined the sensitivity of Cochrane and Epistemonikos. 8 They found similar results with 88% accuracy in Cochrane for RCTs, 82% for observational studies. Epistemonikos had 100% accuracy in both study types 8 . Verdugo-Paiva et al. only looked at Epistemonikos but evaluated both the comprehensiveness and currency, finding comprehensiveness of 100% and the currency of 96.4% 9 . These two studies used different methodologies than this one but came to similar conclusions in the usefulness of these special collections in conducting systematic reviews. All of these evaluations reflect performance at a point in time. As with any source, users must be alert to changes in coverage, indexing practices and timeliness.

Preprints became a very important means for Covid-19 researchers to disseminate findings 10 . The indexing of preprints is reflected in our completeness results to the extent that they were included in the systematic reviews sampled. While we studied the speed of indexing of articles rather than preprints for the currency portion, all collections (but COVID-19 SOLES) actively monitored preprint sites in the same manner as journal sites, so we expect that the speed of inclusion would be similar.

This study has three main limitations. First, both the currency and completeness results represent a particular point in time. Collections may have changed their procedures and the resources allocated to collection maintenance since we took our measurements. For example, COVID-19 SOLES has not updated their database since October 2021. Second, several studies that were marked as not found in the databases were confirmed to be there by the developers of the collections after the fact. These discrepancies may be due to challenges some of the searchers had with the search interfaces/functions of the different databases. Finally, the completeness study is retrospective.

Open-access special collections are an excellent resource for those looking for comprehensive and up-to-date sources. Experienced searchers may prefer PubMed. \

We thank Shaila Mensinkai, advisor to Librarian Reserve Corps, for input during the planning phase of the study. 

We had to be more lenient with the apparent adequacy of the searches for systematic reviews used to identify primary studies. The need for quick information on COVID-19 may have resulted in looser adherence to the usual methods for systematic reviews. 11 Poor reporting of the searches and because many sources used in those reviews, such as preprint servers, had extremely limited search interfaces resulting in the need to perform rudimentary searches. Instead, we increased the minimum number of sources searched to four to help ensure adequate discovery of relevant studies. As Table 1 shows, the selected systematic reviews contained twice as many studies as the excluded studies, suggesting greater success in identifying relevant studies. 

The contribution of databases to the results of systematic reviews: a cross-sectional study

Systematic reviews of epidemiology in diabetes: finding the evidence

Should meta-analysts search Embase in addition to Medline?

Identifying clinical trials in the medical literature with electronic databases: MEDLINE alone is not enough

Systematic reviews of test accuracy should search a range of databases to identify primary studies

Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production

The Librarian Reserve Corps: An Emergency Response

Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19

COVID-19 L·OVE repository is highly comprehensive and can be used as a single source for COVID-19 studies. medRxiv

The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape

The quality of systematic reviews and other synthesis in the time of COVID-19

Contributorship Robyn Butcher contributed in the following roles: data curation, methodology, project administration, resources, supervision, validation, visualization, writing -original draft

Margaret Sampson contributed in the following roles: conceptualization, data curation, formal analysis, investigation, methodology, validation, visualization, writing -original draft, writingreview & editing

Rachel Couban contributed in the following roles: methodology, searching, writing -review & editing

James Malin contributed in the following roles: methodology, searching, writing -review & editing

Sara Loree contributed in the following roles: searching, writing -review & editing Stacy Brody contributed in the following roles: writing -review & editing

We also deviated from the protocol by extending the currency study to get an adequate number of studies. The number of journals that published new studies on COVID-19 during the search period was less than anticipated. In addition, several searchers were unable to complete their searches due to other responsibilities. Therefore, another set of journals were selected using the same process and were monitored until the sample size of primary studies for the currency study reached 50.Appendix 1. Journals selected for tracking for the currency portion of the study, and number of COVID-19 articles published Limitation: our coding, some may not have listed all, for example, all MEDLINE-indexed journals are included in PubMed, but twelve journals that reported that they were indexed in MEDLINE did not also indicate that they were indexed by PubMed. J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:The author(s) declare that there is no conflict of interest.J o u r n a l P r e -p r o o f